UCB SA (UCBJF)
304.84
-0.75
(-0.25%)
USD |
OTCM |
Oct 27, 16:00
UCB Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 19, 2026 | 7.443 |
| October 16, 2026 | 7.484 |
| October 15, 2026 | 7.518 |
| October 14, 2026 | 7.384 |
| October 13, 2026 | 7.384 |
| October 12, 2026 | 7.461 |
| October 09, 2026 | 7.280 |
| October 08, 2026 | 7.406 |
| October 07, 2026 | 7.415 |
| October 06, 2026 | 7.415 |
| October 05, 2026 | 7.368 |
| October 02, 2026 | 7.465 |
| October 01, 2026 | 7.306 |
| September 30, 2026 | 7.718 |
| September 29, 2026 | 7.718 |
| September 28, 2026 | 7.702 |
| September 25, 2026 | 7.375 |
| September 24, 2026 | 7.632 |
| September 23, 2026 | 7.401 |
| September 22, 2026 | 7.401 |
| September 21, 2026 | 7.319 |
| September 18, 2026 | 7.840 |
| September 17, 2026 | 7.734 |
| September 16, 2026 | 7.764 |
| September 15, 2026 | 7.842 |
| Date | Value |
|---|---|
| September 14, 2026 | 7.889 |
| September 11, 2026 | 7.703 |
| September 10, 2026 | 7.252 |
| September 09, 2026 | 7.712 |
| September 08, 2026 | 7.866 |
| September 04, 2026 | 7.991 |
| September 03, 2026 | 7.780 |
| September 02, 2026 | 8.265 |
| September 01, 2026 | 7.891 |
| August 31, 2026 | 7.851 |
| August 28, 2026 | 7.851 |
| August 27, 2026 | 8.374 |
| August 26, 2026 | 8.343 |
| August 25, 2026 | 8.366 |
| August 24, 2026 | 8.366 |
| August 21, 2026 | 8.233 |
| August 20, 2026 | 8.108 |
| August 19, 2026 | 8.178 |
| August 18, 2026 | 7.967 |
| August 17, 2026 | 7.967 |
| August 14, 2026 | 7.967 |
| August 13, 2026 | 8.233 |
| August 12, 2026 | 8.178 |
| August 11, 2026 | 8.274 |
| August 10, 2026 | 8.327 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 8.002 |
| Eli Lilly & Co. | 35.83 |
| Novo Nordisk A/S | 5.000 |
| Pfizer Inc. | 1.972 |
| Teva Pharmaceutical Industries Ltd. | 6.006 |
Price to Book Value Related Metrics
| PE Ratio | 23.12 |
| PS Ratio | 5.950 |
| PEG Ratio | 0.0258 |
| Price to Free Cash Flow | 42.03 |
| Price | 304.84 |
| Earnings Yield | 4.33% |
| Market Cap | 58.12B |
| PEGY Ratio | 0.0258 |
| Operating PE Ratio | 18.69 |
| Normalized PE Ratio | 22.92 |